Crossmark

Use of thromboelastography before the administration of hemostatic agents to safely taper recombinant activated factor VII in acquired hemophilia A: a report of three cases

Crossref DOI link: https://doi.org/10.1186/s12959-022-00387-x

Published Online: 2022-05-16

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hosoi, Hiroki

Akagi, Yuina

Mushino, Toshiki

Takeyama, Masahiro

Minoura, Naoto

Hiroi, Takayuki

Furuya, Yoshiaki

Morimoto, Masaya

Murata, Shogo

Tamura, Shinobu

Sonoki, Takashi
License Information

Text and Data Mining valid from 2022-05-16

Version of Record valid from 2022-05-16
More Information

Article History

Received: 23 February 2022

Accepted: 5 May 2022

First Online: 16 May 2022

Declarations

:

: This study was approved by the ethics committee of Wakayama Medical University (No. 3081). Informed consent was obtained in the form of an opt-out via a website.

: Consent for publication was obtained from the patients.

: The authors declare that they have no conflicts of interest.

Document is current

Any future updates will be listed below